Development and validation of a questionnaire to measure asthma control.

PubWeight™: 9.35‹?› | Rank: Top 0.1%

🔗 View Article (PMID 10573240)

Published in Eur Respir J on October 01, 1999

Authors

E F Juniper1, P M O'Byrne, G H Guyatt, P J Ferrie, D R King

Author Affiliations

1: Dept of Clinical Epidemiology and Biostatistics, McMaster University Faculty of Health Sciences, Hamilton, Ontario, Canada.

Associated clinical trials:

Laminar Airflow in Severe Asthma for Exacerbation Reduction - 48 Month Follow-up. (LASER-48) | NCT02813811

Prescribing Asthma Controller Medication According to Gene Status to Improve Quality of Life in Young People With Asthma (PACT) | NCT02758873

To Determine the Measurement Properties of the ACT in an African American Adolescent Population With Persistent Asthma (ACT AA) | NCT02671643

To Determine the Validity of the ACT in an Adolescent Population With Persistent Asthma (ACT2) | NCT02662413

Dysfunctional Breathing: Characterisation and Assessment | NCT03043469

An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects (BEAM) | NCT03084718

A Dose Ranging Study of CHF 1531 in Asthmatic Subjects (FLASH) | NCT03086460

Allogeneic Human Cells (hMSC) Via Intravenous Delivery in Patients With Mild Asthma (ASTEC) | NCT03137199

Effects of Compression Stockings in Asthma Symptoms at Night | NCT03303586

EMPOWER-PULM (PULMonary Outcomes in Older Adults Empowered With Movement to Prevent Obesity and Weight Regain) (EMPOWER-PULM) | NCT03621098

Corticosteroids/β2-agonists in Hair in Asthmatic Patients (CorticHair) (CorticHair) | NCT03691961

Articles citing this

(truncated to the top 100)

Tiotropium bromide step-up therapy for adults with uncontrolled asthma. N Engl J Med (2010) 6.19

Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter, randomized, double-blind, sham-controlled clinical trial. Am J Respir Crit Care Med (2009) 4.83

Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis. N Engl J Med (2017) 4.55

Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes (2003) 4.41

Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma. J Allergy Clin Immunol (2010) 4.38

Single maintenance and reliever therapy (SMART) of asthma: a critical appraisal. Thorax (2010) 2.86

Effect of beta2-adrenergic receptor polymorphism on response to longacting beta2 agonist in asthma (LARGE trial): a genotype-stratified, randomised, placebo-controlled, crossover trial. Lancet (2009) 2.82

Biomarker-based asthma phenotypes of corticosteroid response. J Allergy Clin Immunol (2014) 2.74

Tailored education may reduce health literacy disparities in asthma self-management. Am J Respir Crit Care Med (2005) 2.71

IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx? Respir Res (2006) 2.66

Forced expiratory flow between 25% and 75% of vital capacity and FEV1/forced vital capacity ratio in relation to clinical and physiological parameters in asthmatic children with normal FEV1 values. J Allergy Clin Immunol (2010) 2.61

Effects of obesity and bariatric surgery on airway hyperresponsiveness, asthma control, and inflammation. J Allergy Clin Immunol (2011) 2.53

Tumour necrosis factor (TNFalpha) as a novel therapeutic target in symptomatic corticosteroid dependent asthma. Thorax (2005) 2.19

A phase II placebo-controlled study of tralokinumab in moderate-to-severe asthma. Eur Respir J (2012) 2.11

Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study. BMC Pulm Med (2006) 2.08

Increased sputum and bronchial biopsy IL-13 expression in severe asthma. J Allergy Clin Immunol (2008) 1.92

Clinical and cost effectiveness of mobile phone supported self monitoring of asthma: multicentre randomised controlled trial. BMJ (2012) 1.87

Asthma outcomes: composite scores of asthma control. J Allergy Clin Immunol (2012) 1.85

A summary of the new GINA strategy: a roadmap to asthma control. Eur Respir J (2015) 1.82

Randomized trial of the effect of drug presentation on asthma outcomes: the American Lung Association Asthma Clinical Research Centers. J Allergy Clin Immunol (2009) 1.81

Does higher body mass index contribute to worse asthma control in an urban population? J Allergy Clin Immunol (2009) 1.79

International consensus on (ICON) pediatric asthma. Allergy (2012) 1.79

Predicting worsening asthma control following the common cold. Eur Respir J (2008) 1.70

Asthma in the elderly: Current understanding and future research needs--a report of a National Institute on Aging (NIA) workshop. J Allergy Clin Immunol (2011) 1.69

Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations. Int J Clin Pract (2007) 1.64

The safety and effects of the beta-blocker, nadolol, in mild asthma: an open-label pilot study. Pulm Pharmacol Ther (2007) 1.61

Influence of leukotriene pathway polymorphisms on response to montelukast in asthma. Am J Respir Crit Care Med (2005) 1.58

Behavioral weight loss and physical activity intervention in obese adults with asthma. A randomized trial. Ann Am Thorac Soc (2015) 1.58

Cluster analysis of obesity and asthma phenotypes. PLoS One (2012) 1.56

Can asthma control be improved by understanding the patient's perspective? BMC Pulm Med (2007) 1.51

Evaluation of airway inflammation by quantitative Th1/Th2 cytokine mRNA measurement in sputum of asthma patients. Thorax (2006) 1.50

Loss of salmeterol bronchoprotection against exercise in relation to ADRB2 Arg16Gly polymorphism and exhaled nitric oxide. Am J Respir Crit Care Med (2013) 1.48

Montelukast as an alternative to low-dose inhaled corticosteroids in the management of mild asthma (the SIMPLE trial): an open-label effectiveness trial. Can Respir J (2009) 1.47

Dietary inflammatory index is related to asthma risk, lung function and systemic inflammation in asthma. Clin Exp Allergy (2015) 1.46

Double blind randomised controlled trial of two different breathing techniques in the management of asthma. Thorax (2006) 1.45

Efficacy of low and high dose inhaled corticosteroid in smokers versus non-smokers with mild asthma. Thorax (2005) 1.44

Overweight children report qualitatively distinct asthma symptoms: analysis of validated symptom measures. J Allergy Clin Immunol (2014) 1.44

Association of dietary soy genistein intake with lung function and asthma control: a post-hoc analysis of patients enrolled in a prospective multicentre clinical trial. Prim Care Respir J (2012) 1.41

Validation and psychometric properties of the Asthma Control Questionnaire among children. J Allergy Clin Immunol (2013) 1.40

A trial of clarithromycin for the treatment of suboptimally controlled asthma. J Allergy Clin Immunol (2010) 1.39

Albuterol Overuse: A Marker of Psychological Distress? J Allergy Clin Immunol Pract (2015) 1.39

Body mass index is associated with reduced exhaled nitric oxide and higher exhaled 8-isoprostanes in asthmatics. Respir Res (2007) 1.33

Vigorous Exercise Can Cause Abnormal Pulmonary Function in Healthy Adolescents. Ann Am Thorac Soc (2015) 1.29

The effects of combining Web-based eHealth with telephone nurse case management for pediatric asthma control: a randomized controlled trial. J Med Internet Res (2012) 1.19

Quantitative analysis of high-resolution computed tomography scans in severe asthma subphenotypes. Thorax (2010) 1.19

Ventilation heterogeneity is a major determinant of airway hyperresponsiveness in asthma, independent of airway inflammation. Thorax (2007) 1.14

Montelukast as add-on therapy with inhaled corticosteroids alone or inhaled corticosteroids and long-acting beta-2-agonists in the management of patients diagnosed with asthma and concurrent allergic rhinitis (the RADAR trial). Can Respir J (2009) 1.11

Association of obstructive sleep apnea risk with asthma control in adults. Chest (2010) 1.09

Targeted routine asthma care in general practice using telephone triage. Br J Gen Pract (2005) 1.08

The association of health literacy with adherence and outcomes in moderate-severe asthma. J Allergy Clin Immunol (2013) 1.08

Weekly self-monitoring and treatment adjustment benefit patients with partly controlled and uncontrolled asthma: an analysis of the SMASHING study. Respir Res (2010) 1.06

Targeting key proximal drivers of type 2 inflammation in disease. Nat Rev Drug Discov (2015) 1.05

The Asthma Control and Communication Instrument: a clinical tool developed for ethnically diverse populations. J Allergy Clin Immunol (2008) 1.05

Use of health information technology to improve medication adherence. Am J Manag Care (2011) 1.03

Correlation between the Korean version of Asthma Control Test and health-related quality of life in adult asthmatics. J Korean Med Sci (2008) 1.03

Individual-level socioeconomic status is associated with worse asthma morbidity in patients with asthma. Respir Res (2009) 1.02

The Breathe Easier through Weight Loss Lifestyle (BE WELL) Intervention: a randomized controlled trial. BMC Pulm Med (2010) 1.00

Managing asthma in primary care: putting new guideline recommendations into context. Mayo Clin Proc (2009) 1.00

Effects of short-term treatment with atorvastatin in smokers with asthma--a randomized controlled trial. BMC Pulm Med (2011) 1.00

Distribution of sputum cellular phenotype in a large asthma cohort: predicting factors for eosinophilic vs neutrophilic inflammation. BMC Pulm Med (2013) 0.99

A smarter way to manage asthma with a combination of a long-acting beta(2)-agonist and inhaled corticosteroid. Ther Clin Risk Manag (2007) 0.99

Development of the ATAQ-IPF: a tool to assess quality of life in IPF. Health Qual Life Outcomes (2010) 0.98

Symptom reporting in childhood asthma: a comparison of assessment methods. Arch Dis Child (2006) 0.98

Parents were accurate proxy reporters of urgent pediatric asthma health services: a retrospective agreement analysis. J Clin Epidemiol (2007) 0.98

Cost-effectiveness of Internet-based self-management compared with usual care in asthma. PLoS One (2011) 0.97

Detrimental effects of environmental tobacco smoke in relation to asthma severity. PLoS One (2011) 0.97

Asthma symptom utility index: reliability, validity, responsiveness, and the minimal important difference in adult asthmatic patients. J Allergy Clin Immunol (2012) 0.96

Complexity of chronic asthma and chronic obstructive pulmonary disease: implications for risk assessment, and disease progression and control. Lancet (2008) 0.96

Introduction of Asthma APGAR tools improve asthma management in primary care practices. J Asthma Allergy (2008) 0.96

Montelukast as add-on therapy to inhaled corticosteroids in the management of asthma (the SAS trial). Can Respir J (2009) 0.95

Assessment of disease control in allergic rhinitis. Clin Transl Allergy (2013) 0.95

Health-related quality of life in Polish adolescents with Hymenoptera venom allergy treated with venom immunotherapy. Arch Med Sci (2012) 0.95

The use of β2-agonist therapy before hospital attendance for severe asthma exacerbations: a post-hoc analysis. NPJ Prim Care Respir Med (2015) 0.95

Measurement of asthma control according to Global Initiative for Asthma guidelines: a comparison with the Asthma Control Questionnaire. Respir Res (2012) 0.95

Asthma outcomes: symptoms. J Allergy Clin Immunol (2012) 0.93

Association of corticotropin-releasing hormone receptor-2 genetic variants with acute bronchodilator response in asthma. Pharmacogenet Genomics (2008) 0.93

Relationship between body composition, inflammation and lung function in overweight and obese asthma. Respir Res (2012) 0.93

Poor adherence with inhaled corticosteroids for asthma: can using a single inhaler containing budesonide and formoterol help? Br J Gen Pract (2008) 0.93

Partner randomized controlled trial: study protocol and coaching intervention. BMC Pediatr (2012) 0.93

Internet telehealth for pediatric asthma case management: integrating computerized and case manager features for tailoring a Web-based asthma education program. Health Promot Pract (2006) 0.92

IL-13-producing BLT1-positive CD8 cells are increased in asthma and are associated with airway obstruction. Allergy (2013) 0.92

From the female perspective: Long-term effects on quality of life of a program for women with asthma. Gend Med (2010) 0.92

Poor asthma control and exposure to traffic pollutants and obesity in older adults. Ann Allergy Asthma Immunol (2012) 0.92

Association of obstructive sleep apnea risk or diagnosis with daytime asthma in adults. J Asthma (2012) 0.92

Towards tailored and targeted adherence assessment to optimise asthma management. NPJ Prim Care Respir Med (2015) 0.92

Characteristic DNA methylation profiles in peripheral blood monocytes are associated with inflammatory phenotypes of asthma. Epigenetics (2014) 0.92

A qualitative analysis of a dyad approach to health-related quality of life measurement in children with asthma. Soc Sci Med (2006) 0.91

Obesity and exercise habits of asthmatic patients. Ann Allergy Asthma Immunol (2008) 0.91

Randomised placebo-controlled study of the effect of paracetamol on asthma severity in adults. BMJ Open (2014) 0.91

Control of Allergic Rhinitis and Asthma Test (CARAT) can be used to assess individual patients over time. Clin Transl Allergy (2012) 0.90

Short-term diesel exhaust inhalation in a controlled human crossover study is associated with changes in DNA methylation of circulating mononuclear cells in asthmatics. Part Fibre Toxicol (2014) 0.90

The association between asthma control, health care costs, and quality of life in France and Spain. BMC Pulm Med (2013) 0.90

MicroRNA expression in response to controlled exposure to diesel exhaust: attenuation by the antioxidant N-acetylcysteine in a randomized crossover study. Environ Health Perspect (2013) 0.90

Control of allergic rhinitis and asthma test--a formal approach to the development of a measuring tool. Respir Res (2009) 0.89

Validation of Persian Version of Asthma Control Test Based on new Global Initiative for Asthma Guidelines. Tanaffos (2011) 0.89

A randomized, controlled trial to evaluate the effect of an anti-interleukin-9 monoclonal antibody in adults with uncontrolled asthma. Respir Res (2013) 0.88

Development and validation of database indexes of asthma severity and control. Thorax (2007) 0.88

Effects of obstructive sleep apnea and gastroesophageal reflux disease on asthma control in obesity. J Asthma (2011) 0.88

Indicators of asthma control among students in a rural, school-based asthma management program. J Asthma (2014) 0.87

Airway hyperresponsiveness in asthma: mechanisms, clinical significance, and treatment. Front Physiol (2012) 0.87

Articles by these authors

Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials (1989) 15.99

Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. JAMA (1994) 13.60

Guidelines for reading literature reviews. CMAJ (1988) 10.90

Users' guides to the medical literature. VI. How to use an overview. Evidence-Based Medicine Working Group. JAMA (1994) 10.80

Determining a minimal important change in a disease-specific Quality of Life Questionnaire. J Clin Epidemiol (1994) 9.50

The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. J Clin Epidemiol (1997) 9.01

The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J (1985) 8.06

How to keep up with the medical literature: V. Access by personal computer to the medical literature. Ann Intern Med (1986) 7.36

Users' guides to the medical literature. I. How to get started. The Evidence-Based Medicine Working Group. JAMA (1993) 6.83

Measuring quality of life in children with asthma. Qual Life Res (1996) 6.76

A consumer's guide to subgroup analyses. Ann Intern Med (1992) 6.34

Users' guides to the medical literature: XXII: how to use articles about clinical decision rules. Evidence-Based Medicine Working Group. JAMA (2000) 5.94

Measuring disease-specific quality of life in clinical trials. CMAJ (1986) 5.56

Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax (1992) 5.37

Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group. N Engl J Med (1994) 5.19

Measuring quality of life in asthma. Am Rev Respir Dis (1993) 4.97

Randomised controlled trial of respiratory rehabilitation. Lancet (1994) 4.74

Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. Lancet (1996) 4.65

Assessing the minimal important difference in symptoms: a comparison of two techniques. J Clin Epidemiol (1996) 4.55

Validation of an index of the quality of review articles. J Clin Epidemiol (1991) 4.54

Cardiac rehabilitation after myocardial infarction. Combined experience of randomized clinical trials. JAMA (1988) 4.46

Effect of encouragement on walking test performance. Thorax (1984) 4.44

Practitioners of evidence based care. Not all clinicians need to appraise evidence from scratch but all need some skills. BMJ (2000) 4.41

The science of reviewing research. Ann N Y Acad Sci (1993) 4.15

Bronchial responsiveness to histamine or methacholine in asthma: measurement and clinical significance. J Allergy Clin Immunol (1981) 4.03

Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Intern Med (1998) 4.01

Development and validation of the Mini Asthma Quality of Life Questionnaire. Eur Respir J (1999) 4.00

Systematic implementation of an advance directive program in nursing homes: a randomized controlled trial. JAMA (2000) 3.87

Airway responsiveness. Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl (1993) 3.82

Measuring quality of life in the parents of children with asthma. Qual Life Res (1996) 3.82

The influence of dietary and nondietary calcium supplementation on blood pressure: an updated metaanalysis of randomized controlled trials. Am J Hypertens (1999) 3.72

Canadian physicians' attitudes about and preferences regarding clinical practice guidelines. CMAJ (1997) 3.56

Users' guides to the medical literature. JAMA (1993) 3.56

Users' guides to the medical literature: XX. Integrating research evidence with the care of the individual patient. Evidence-Based Medicine Working Group. JAMA (2000) 3.33

Physician interpretations and textbook definitions of blinding terminology in randomized controlled trials. JAMA (2001) 3.32

Validation of a standardized version of the Asthma Quality of Life Questionnaire. Chest (1999) 3.28

Interpreting small differences in functional status: the Six Minute Walk test in chronic lung disease patients. Am J Respir Crit Care Med (1997) 3.28

Stress ulcer prophylaxis in critically ill patients. Resolving discordant meta-analyses. JAMA (1996) 3.21

Intention-to-treat principle. CMAJ (2001) 3.20

A new perspective on concepts of asthma severity and control. Eur Respir J (2008) 3.16

Determinants in Canadian health care workers of the decision to withdraw life support from the critically ill. Canadian Critical Care Trials Group. JAMA (1995) 3.08

Effect of HMGcoA reductase inhibitors on stroke. A meta-analysis of randomized, controlled trials. Ann Intern Med (1998) 3.07

Endoscopic therapy for acute nonvariceal upper gastrointestinal hemorrhage: a meta-analysis. Gastroenterology (1992) 3.06

Isoniazid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomized controlled trials. AIDS (1999) 3.04

Clinical impact versus factor analysis for quality of life questionnaire construction. J Clin Epidemiol (1997) 2.98

Effect of calcium supplementation on pregnancy-induced hypertension and preeclampsia: a meta-analysis of randomized controlled trials. JAMA (1996) 2.98

How to keep up with the medical literature: I. Why try to keep up and how to get started. Ann Intern Med (1986) 2.94

When should an effective treatment be used? Derivation of the threshold number needed to treat and the minimum event rate for treatment. J Clin Epidemiol (2001) 2.84

Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest (1992) 2.81

Inhibition of exercise-induced bronchoconstriction by MK-571, a potent leukotriene D4-receptor antagonist. N Engl J Med (1990) 2.80

Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy (1991) 2.80

A menopause-specific quality of life questionnaire: development and psychometric properties. Maturitas (1996) 2.74

Residents' experiences of abuse, discrimination and sexual harassment during residency training. McMaster University Residency Training Programs. CMAJ (1996) 2.71

Reamed versus nonreamed intramedullary nailing of lower extremity long bone fractures: a systematic overview and meta-analysis. J Orthop Trauma (2000) 2.69

The rational clinical examination. Is this patient having a myocardial infarction? JAMA (1998) 2.66

How should we measure function in patients with chronic heart and lung disease? J Chronic Dis (1985) 2.61

User's guide to the orthopaedic literature: how to use an article about a surgical therapy. J Bone Joint Surg Am (2001) 2.58

Treatment of asthma with drugs modifying the leukotriene pathway. N Engl J Med (1999) 2.53

Users' guides to the medical literature: XIV. How to decide on the applicability of clinical trial results to your patient. Evidence-Based Medicine Working Group. JAMA (1998) 2.52

Clinical recommendations using levels of evidence for antithrombotic agents. Chest (1995) 2.52

Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2002) 2.50

An index of scientific quality for health reports in the lay press. J Clin Epidemiol (1993) 2.47

Relation of distribution- and anchor-based approaches in interpretation of changes in health-related quality of life. Med Care (2001) 2.36

Sensitivity to change of the Roland-Morris Back Pain Questionnaire: part 1. Phys Ther (1998) 2.35

Treatment of open fractures of the shaft of the tibia. J Bone Joint Surg Br (2001) 2.33

Selective decontamination of the digestive tract. An overview. Chest (1994) 2.28

Should unpublished data be included in meta-analyses? Current convictions and controversies. JAMA (1993) 2.26

A framework for clinical evaluation of diagnostic technologies. CMAJ (1986) 2.26

Agreement among reviewers of review articles. J Clin Epidemiol (1991) 2.25

Children and adult perceptions of childhood asthma. Pediatrics (1997) 2.25

Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics. Am Rev Respir Dis (1990) 2.23

Practice guidelines. What are internists looking for? J Gen Intern Med (1996) 2.17

Should study subjects see their previous responses? J Chronic Dis (1985) 2.17

Transferring evidence from research into practice: 1. The role of clinical care research evidence in clinical decisions. ACP J Club (1996) 2.10

Effects of dietary calcium supplementation on blood pressure. A meta-analysis of randomized controlled trials. JAMA (1996) 2.08

Late asthmatic responses. Am Rev Respir Dis (1987) 2.05

How to use an article on therapy or prevention: pneumonia prevention using subglottic secretion drainage. Crit Care Med (1997) 2.03

Grading quality of evidence and strength of recommendations in clinical practice guidelines. Part 1 of 3. An overview of the GRADE approach and grading quality of evidence about interventions. Allergy (2009) 1.97

Exacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACET International Study Group. Am J Respir Crit Care Med (1999) 1.96

Users' guides to the medical literature: XVII. How to use guidelines and recommendations about screening. Evidence-Based Medicine Working Group. JAMA (1999) 1.96

Quality of life in stage II breast cancer: an instrument for clinical trials. J Clin Oncol (1988) 1.93

Induced sputum cell counts in healthy adults. Am J Respir Crit Care Med (2000) 1.93

Distribution of intranasal instillations in mice: effects of volume, time, body position, and anesthesia. Am J Physiol Lung Cell Mol Physiol (2002) 1.92

Users' guides to the medical literature. XI. How to use an article about a clinical utilization review. Evidence-Based Medicine Working Group. JAMA (1996) 1.91

Long-term effects of outpatient rehabilitation of COPD: A randomized trial. Chest (2000) 1.91

Development of a self-reported Chronic Respiratory Questionnaire (CRQ-SR). Thorax (2001) 1.89

Importance of airway inflammation for hyperresponsiveness induced by ozone. Am Rev Respir Dis (1983) 1.85

Bronchodilators in chronic air-flow limitation. Effects on airway function, exercise capacity, and quality of life. Am Rev Respir Dis (1987) 1.85

Development and validation of the mini Rhinoconjunctivitis Quality of Life Questionnaire. Clin Exp Allergy (2000) 1.85

Users' guides to the medical literature: XIX. Applying clinical trial results. A. How to use an article measuring the effect of an intervention on surrogate end points. Evidence-Based Medicine Working Group. JAMA (1999) 1.84

Interpretation of treatment changes in 6-minute walk distance in patients with COPD. Eur Respir J (2008) 1.82

Interobserver variation in interpreting chest radiographs for the diagnosis of acute respiratory distress syndrome. Am J Respir Crit Care Med (2000) 1.81